Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug recognized in Canada for addressing Attention-Deficit/Hyperactivity Dysfunction in children and people. The medication functions as a prodrug, https://vyvanse-in-canada333586.full-design.com/vyvanse-in-canada-a-comprehensive-explanation-86160685